Filing Details

Accession Number:
0001209191-22-051379
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-09-27 18:14:26
Reporting Period:
2022-09-23
Accepted Time:
2022-09-27 18:14:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1806952 Lyell Immunopharma Inc. LYEL () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591178 Richard Klausner C/O Lyell Immunopharma, Inc.
201 Haskins Way
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-09-23 11,100 $6.40 988,900 No 4 S Indirect Grantor
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Grantor
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 2,967,834 Direct
Footnotes
  1. Consists of 250,000 shares held by The Ariella Klausner Delaware Trust, 238,900 shares held by The Eli Klausner Delaware Trust, 250,000 shares held by The Isaac Klausner Delaware Trust, and 250,000 shares held by The Olivia Klausner Delaware Trust. The Reporting Person is a grantor of each of the trusts and disclaims beneficial ownership of all shares held by the trusts except to any pecuniary interest therein. Raymond James Trust Services of Delaware is the trustee of each of the trusts.